Complete Filing Data
Alpha Tau Medical Ltd. reported Stockholders Equity of $77.10 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Alpha Tau Medical Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Net Income * | -$42.6M | -$31.8M | -$29.2M | -$33.8M | -$27.3M | -$8.9M | -$8.4M |
| Research And Development Expense | $32.1M | $27.0M | $26.4M | $20.9M | $11.4M | $7.5M | $6.6M |
| Operating Income Loss | -$42.3M | -$36.0M | -$35.7M | -$32.1M | -$13.8M | -$9.2M | $8.0M |
| Income Tax Expense Benefit | $121.0K | $6.0K | $16.0K | $20.0K | $7.0K | $158.0K | -$146.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$42.5M | -$31.7M | -$29.1M | -$33.7M | -$27.3M | -$8.7M | $8.3M |
| General And Administrative Expense | $8.4M | $6.7M | $7.3M | $10.3M | $1.9M | $1.4M | $977.0K |
| Income Taxes Paid | $4.0K | $5.0K | $16.0K | $8.0K | $1.0K | $2.0K | |
| Comprehensive Income Net Of Tax | -$42.6M | -$31.8M | -$29.2M | -$33.8M | -$27.3M | -$8.9M | |
| Nonoperating Gains Losses | -$1.6M | -$13.5M | $520.0K | $308.0K | |||
| Nonoperating Income Expense | -$218.0K | $4.3M | $6.5M | -$1.6M | -$13.5M | ||
| Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest | -$27.3M | -$8.9M | -$8.5M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $77.1M | $62.7M | $84.5M | $105.7M | -$34.8M | -$8.4M | -$193.0K | $1.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $12.2M | $13.7M | $12.7M | $6.7M | $23.9M | $16.2M | $1.8M | $13.6M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.5M | $1.1M | $6.0M | -$17.2M | $7.7M | $14.3M | -$11.8M | |
| Cash And Cash Equivalents At Carrying Value | $12.2M | $13.7M | $12.7M | $5.8M | $23.2M | $15.6M | ||
| Retained Earnings Accumulated Deficit | -$190.1M | -$147.5M | -$115.8M | -$86.6M | -$52.8M | -$25.6M | ||
| Property Plant And Equipment Net | $19.7M | $13.9M | $12.8M | $7.5M | $7.5M | $5.4M | ||
| Prepaid Expense And Other Assets Current | $1.4M | $1.4M | $816.0K | $1.1M | $707.0K | $864.0K | ||
| Liabilities Current | $10.5M | $8.7M | $7.1M | $4.3M | $4.4M | $2.1M | ||
| Liabilities And Stockholders Equity | $105.7M | $86.2M | $107.4M | $120.1M | $42.2M | $53.0M | ||
| Liabilities | $28.6M | $23.5M | $22.9M | $14.5M | $23.0M | $7.5M | ||
| Assets Current | $78.3M | $64.2M | $85.8M | $106.5M | $32.6M | $47.5M | ||
| Assets | $105.7M | $86.2M | $107.4M | $120.1M | $42.2M | $53.0M | ||
| Assets Noncurrent | $27.4M | $22.0M | $21.6M | $13.7M | $9.6M | $5.5M | ||
| Short Term Investments | $60.9M | $45.9M | $69.1M | $98.7M | $8.1M | |||
| Other Accounts Payable And Accrued Liabilities | $5.5M | $4.1M | $3.5M | $2.2M | $3.2M | |||
| Restricted Investments Current | $3.8M | $3.3M | $3.2M | $8.1M | $30.4M | |||
| Restricted Cash And Cash Equivalents At Carrying Value | $850.0K | $618.0K | $576.0K | |||||
| Operating Lease Right Of Use Asset | $7.2M | $7.6M | $8.4M | $5.8M | ||||
| Operating Lease Liability Noncurrent | $6.2M | $6.0M | $6.6M | $4.5M | ||||
| Operating Lease Liability Current | $1.1M | $1.0M | $1.1M | $669.0K | ||||
| Accounts Payable Current | $2.6M | $1.4M | $1.2M | $964.0K | ||||
| Liabilities Noncurrent | $18.0M | $14.9M | $15.8M | $10.2M | ||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $422.0K | $35.0K | $3.3M | |||||
| Long Term Loans Payable | $6.4M | $5.6M | $5.6M | |||||
| Additional Paid In Capital Common Stock | $267.2M | $210.2M | $200.2M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Share Based Compensation | $10.6M | $9.9M | $7.9M | $6.7M | $812.0K | $596.0K | $546.0K |
| Payments To Acquire Property Plant And Equipment | $6.1M | $2.2M | $6.4M | $904.0K | $2.9M | $3.8M | $1.3M |
| Net Cash Provided By Used In Operating Activities | -$26.7M | -$19.8M | -$18.0M | -$23.9M | -$11.8M | -$7.3M | -$6.9M |
| Net Cash Provided By Used In Investing Activities | -$20.6M | $20.8M | $18.7M | -$89.9M | $19.3M | -$7.8M | -$10.2M |
| Net Cash Provided By Used In Financing Activities | $45.8M | $25.0K | $5.3M | $96.9M | $111.0K | $29.3M | $5.3M |
| Increase Decrease In Prepaid Expenses Other | $47.0K | -$39.0K | $80.0K | -$1.6M | $1.9M | $123.0K | $16.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $21.0K | $558.0K | -$281.0K | $341.0K | -$157.0K | -$283.0K | $509.0K |
| Increase Decrease In Accounts Payable Trade | $337.0K | $965.0K | $1.1M | $220.0K | $239.0K | $114.0K | $148.0K |
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$21.0K | $57.0K | -$50.0K | -$258.0K | $108.0K | $84.0K | -$18.0K |
| Proceeds From Stock Options Exercised | $272.0K | $25.0K | $49.0K | $27.0K | $111.0K | $20.0K | |
| Proceeds From Sale Maturity And Collection Of Shortterm Investments | $56.0M | $148.2M | $191.9M | $32.1M | $30.3M | $66.2M | |
| Payments To Acquire Short Term Investments | $70.5M | $125.1M | $163.6M | $121.1M | $8.1M | $70.2M | |
| Increase Decrease In Other Accounts Payable And Accrued Liabilities | $1.1M | $659.0K | $1.2M | -$1.2M | $2.1M | $625.0K | |
| Increase Decrease In Non Cash Financial Income Expenses | $1.3M | -$29.0K | $153.0K | -$12.0K | |||
| Increase Decrease In Operating Lease Liability | -$23.0K | -$726.0K | -$809.0K | -$1.2M | |||
| Proceeds From Warrant Exercises | $3.3M | $571.0K | $1.0M | ||||
| Increase Decrease In Other Operating Capital Net | -$789.0K | -$729.0K | -$535.0K | ||||
| Increase Decrease In Other Accrued Liabilities | $2.1M | $625.0K | $313.0K | ||||
| Increase Decrease In Fair Value Of Warrants Convertible Preferred Shares | 13.3M | 203.0K | 994.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 80.6M | 69.9M | 69.4M | 63.5M | 40.5M | 40.3M | 33.8M |
| Weighted Average Number Of Diluted Shares Outstanding | 80.6M | 69.9M | 69.4M | 63.5M | 40.5M | 40.3M | 33.8M |
| Earnings Per Share Diluted | $-0.53 | $-0.45 | $-0.42 | $-0.53 | $-0.67 | $-0.22 | $-0.25 |
| Earnings Per Share Basic | $-0.53 | $-0.45 | $-0.42 | $-0.53 | $-0.67 | $-0.22 | $-0.25 |
| Common Stock Shares Outstanding | 88.0M | 70.4M | 69.7M | 69.1M | 40.5M | 40.4M | |
| Common Stock Shares Issued | 88.0M | 70.4M | 69.7M | 69.1M | 40.5M | 40.4M | |
| Common Stock Shares Authorized | 362.1M | 362.1M | 362.1M | 362.1M | 72.4M | 72.4M | |
| Temporary Equity Shares Issued | 0.00 | 13.7M | 13.7M | ||||
| Temporary Equity Shares Authorized | 0.00 | 25.3M | 25.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Marketing Expense | $1.9M | $2.3M | $1.9M | $974.0K | $482.0K | $288.0K | $397.0K |
| Depreciation | $1.2M | $1.1M | $1.1M | $979.0K | $776.0K | $86.0K | $66.0K |
| Interest Paid Net | $381.0K | $321.0K | $52.0K | $237.0K | $351.0K | $541.0K | $780.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $10.6M | $9.9M | $7.9M | $6.7M | $812.0K | $596.0K | $546.0K |
| Prepaid Expense Noncurrent | $479.0K | $432.0K | $471.0K | $391.0K | $2.0M | $139.0K | |
| Stock Issued During Period Value Exercise Of Warrants | $3.3M | $0.00 | $30.0K | $1.6M | |||
| Stock Issued During Period Value Stock Options Exercised | $272.0K | $25.0K | $49.0K | $27.0K | $111.0K | ||
| Other Noncash Income Expense | $245.0K | -$40.0K | -$1.7M | $1.3M | -$29.0K | ||
| Interest Received | $2.8M | $4.4M | $6.2M | $237.0K | $351.0K | ||
| Fair Value Adjustment Of Warrants | -$259.0K | -$2.0M | $3.8M | $13.3M | $203.0K | ||
| Additional Paid In Capital | $200.2M | $192.3M | $18.1M | $17.1M | |||
| Stock Issued During Period Value Ordinary Shares Upon Exercise Of Share Options | 27.0K | 111.0K | 20.0K | ||||
| Warrants And Rights Outstanding | $5.4M | $3.3M | $3.6M | ||||
| Warrantliability | $5.6M | $18.6M | $5.4M | ||||
| Adjustments To Additional Paid In Capital Warrant Issued | $35.2M | $5.3M |
Most recent annual filing with the SEC: March 9, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.